Genomic alterations in breast cancer: level ofevidence for actionability
Genomic alterations in breast cancer: level ofevidence for actionability according to ESMO Scale forClinical Actionability of molecular Targets (ESCAT)
https://www.annalsofoncology.org/art...092-0/fulltext
Nguyen
|